Diagnostic differences and agreement between the original and revised European Working Group (EWGSOP) consensus definition for sarcopenia in community-dwelling older adults with type 2 diabetes mellitus

Villani, Anthony; McClure, Rebecca; Barrett, Michelle; Scott, David

doi:10.1016/j.archger.2020.104081

Cited by 22 publications

(21 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of sarcopenia varies between 2% and 4% according to EWGSOP2. It is lower than prevalence of sarcopenia by AWGS algorithm, and it is similar to our study (27,28).…”

Section: Discussionsupporting

confidence: 90%

Geriatri polikliniğine başvuran tip 2 diabetes mellituslu hastalarda kas gücü ve kas kütlesinin vücut kitle indeksi ve insülin tedavisiyle ilişkisi

2021

View full text Add to dashboard Cite

Aim:The aim of this study was to investigate the hand grip strength and muscle mass of older patients with type 2 diabetes mellitus in relation to body mass index and insulin treatment. Materials and Methods: A total of 123 older patients with diabetes mellitus ≥65 years of age were admitted to geriatric outpatient clinic of a university hospital between October 2015 and October 2019. Demographic data, medical records, laboratory results, hand grip strength and muscle mass were derived from the hospital records, retrospectively. Results: The patients were grouped according to body mass index and usage of insulin treatment. There was a negative correlation between body mass index and hand grip strength (p = 0,002), and a positive correlation between body mass index and muscle mass index (p = 0,001). No significant differences for hand grip strength and muscle mass index were observed between insulin treatment group and non-insulin treatment group. Conclusion:In type 2 diabetes mellitus patients with normal weight and obesity, anthropometric differences should be considered to identify true sarcopenic patients. Assessment of muscle strength, and also evaluation of muscle quality might be more valuable than assessment of muscle mass for those patients.

show abstract

“…The prevalence of sarcopenia varies between 2% and 4% according to EWGSOP2. It is lower than prevalence of sarcopenia by AWGS algorithm, and it is similar to our study (27,28).…”

Section: Discussionsupporting

confidence: 90%

Geriatri polikliniğine başvuran tip 2 diabetes mellituslu hastalarda kas gücü ve kas kütlesinin vücut kitle indeksi ve insülin tedavisiyle ilişkisi

2021

View full text Add to dashboard Cite

show abstract

“…One of the most accepted was described by the EWGSOP (European Working Group on Sarcopenia in Older Persons), updated in 2018 (EWGSOP2), considering sarcopenia as a "progressive loss of muscle mass and muscle strength, associated to an increased likelihood of adverse events, such as falls, fractures, physical disability and death" [7]. Several authors investigated the differences in sarcopenia cases, agreeing with EWGSOP1 and EWGSOP2 and noting substantial discordance and limited overlap of the definitions [11,12]. Nevertheless, the EWGSOP2 is crucial suggestion to evaluate a possible condition of sarcopenia by measuring the muscle strength, muscle mass and physical performance [13].…”

Section: Introductionmentioning

confidence: 99%

Diagnosis, Treatment and Prevention of Sarcopenia in Hip Fractured Patients: Where We Are and Where We Are Going: A Systematic Review

Testa

Vescio

Zuccalà

et al. 2020

JCM

View full text Add to dashboard Cite

Background: Sarcopenia is defined as a progressive loss of muscle mass and muscle strength associated to increased adverse events, such as falls and hip fractures. The aim of this systematic review is to analyse diagnosis methods of sarcopenia in patients with hip fracture and evaluate prevention and treatment strategies described in literature. Methods: Three independent authors performed a systematic review of two electronic medical databases using the following inclusion criteria: Sarcopenia, hip fractures, diagnosis, treatment, and prevention with a minimum average of 6-months follow-up. Any evidence-level studies reporting clinical data and dealing with sarcopenia diagnosis, or the treatment and prevention in hip fracture-affected patients, were considered. Results: A total of 32 articles were found. After the first screening, we selected 19 articles eligible for full-text reading. Ultimately, following full-text reading, and checking of the reference list, seven articles were included. Conclusions: Sarcopenia diagnosis is challenging, as no standardized diagnostic and therapeutic protocols are present. The development of medical management programs is mandatory for good prevention. To ensure adequate resource provision, care models should be reviewed, and new welfare policies should be adopted in the future.

show abstract

“…To our knowledge at present there is no normative data for grip strength for the Australian population. Villani [ 47 ] recently compared both EWGSOP criteria in an Australian population. They report a significant discordance between both definitions of sarcopenia.…”

Section: Discussionmentioning

confidence: 99%

Sarcopenia in women with hip fracture: A comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function

Yee

Hau

Taylor

et al. 2020

Osteoporosis and Sarcopenia

View full text Add to dashboard Cite

Diagnostic differences and agreement between the original and revised European Working Group (EWGSOP) consensus definition for sarcopenia in community-dwelling older adults with type 2 diabetes mellitus

Cited by 22 publications

References 40 publications

Geriatri polikliniğine başvuran tip 2 diabetes mellituslu hastalarda kas gücü ve kas kütlesinin vücut kitle indeksi ve insülin tedavisiyle ilişkisi

Geriatri polikliniğine başvuran tip 2 diabetes mellituslu hastalarda kas gücü ve kas kütlesinin vücut kitle indeksi ve insülin tedavisiyle ilişkisi

Diagnosis, Treatment and Prevention of Sarcopenia in Hip Fractured Patients: Where We Are and Where We Are Going: A Systematic Review

Sarcopenia in women with hip fracture: A comparison of hormonal biomarkers and their relationship to skeletal muscle mass and function

Contact Info

Product

Resources

About